Pancreatic Cancer Research

ResearcherAffiliated Hospital of Jiangsu UniversityActive in the last 2 years

Min Xu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5133335675. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Exosomal hnRNPA2B1 suppresses irinotecan-induced ferroptosis in pancreatic cancer. Last author DOI 10.1016/j.hbpd.2026.04.002↗
  2. Exosomes: Emerging Insights into the Progression of Pancreatic Cancer. Co-author DOI 10.7150/ijbs.97076↗
  3. Hypoxia-elicited Exosomes Promote the Chemoresistance of Pancreatic Cancer Cells by Transferring LncROR via Hippo Signaling. Last author DOI 10.7150/jca.81320↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xu-Lin Zhou · 1 shared paper, 2026 · strength 0.32
  2. Yongmin Yan · 1 shared paper, 2024 · strength 0.28
  3. Xulin Zhou · 1 shared paper, 2024 · strength 0.28
  4. Wenrong Xu · 1 shared paper, 2024 · strength 0.28
  5. Aihua Gong · 1 shared paper, 2023 · strength 0.19
  6. Huizhi Wang · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.